Severity
Low
FDA Drug recall · Reported October 11, 2017
Failed Impurities/Degradation Specifications.
Vi-Jon, Inc. recalled Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz (… - a low-severity action.
Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz (… was recalled by Vi-Jon, Inc. in October 11, 2017. Reason: Failed Impurities/Degradation Specifications.. Check the official notice for the remedy. Verify recall #D-0006-2018 with the FDA Drug before acting.
The recall
Vi-Jon, Inc. issued this low-severity FDA Drug recall-Failed Impurities/Degradation Specifications..
Sourced from official FDA Drug enforcement records. Verify recall #D-0006-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0006-2018) was formally reported on October 11, 2017, with the manufacturer initiating the action on September 13, 2017. It is classified under Low severity (Class III), with a current status of Terminated. Vi-Jon, Inc. is listed as the recalling firm, operating out of Smyrna, TN. Federal records list the affected scope as 87,972 bottles.
The documented reason for this recall is: Failed Impurities/Degradation Specifications. Distribution data in the federal record shows the product reached: United States and Canada. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
87,972 bottles
Related Recalls
6
5 from same agency
Magnesium Citrate Oral Solution Cherry Flavor, 1.745 g per fl oz, packaged in 10 fl. oz ( 296 mL) bottles, Labeled as a) CVS Health, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895; NDC 6984238038, UPC 050428418321, b) Meijer, Dist. By Meijer Distribution, Inc. Grand Rapids, MI 49544, NDC 4125038038, UPC 708820824294, c) Life Brand, Manufactured for: Shoppers Drug Mark/Pharmaprix Toronto, UPC 057800856405
Failed Impurities/Degradation Specifications.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0006-2018 |
| Date reported | October 11, 2017 |
| Date initiated | September 13, 2017 |
| Recalling firm | Vi-Jon, Inc. |
| Firm location | Smyrna, TN |
| Affected scope | 87,972 bottles |
| Distribution | United States and Canada |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported October 11, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.